Fireogtreds procent af patienterne havde nedsat performance status (ECOG 1 eller 2) ved indgang i undersøgelsen; 79% havde viscerale metastaser; og 76% havde > 3 metastaselokalisationer.
Sixty-four percent of patients had impaired performance status (ECOG 1 or 2) at study entry; 79% had visceral metastases; and 76% had > 3 sites of metastases.